Treatments for multiple sclerosis (MS) can control relapses, but don’t stop the disease from progressing—or promote brain repair.
But with financial support...
Case Western Reserve University researcher Farren Briggs was awarded $1.2 million over three years from the National Institute of Neurological Disorders and St...
Created by Case Western Reserve University researchers, the drug will be tested in healthy volunteers at Cleveland Clinic Mellen Center for Multiple Sclerosis
...
Convelo Therapeutics Inc., a company founded on seminal scientific discoveries made in the laboratories of Paul Tesar and Drew Adams at Case Western Reserve Uni...
Dozens of drug candidates identified that share a common mechanism to stimulate regeneration of the brain’s myelinating cells
Research published today in the j...
With geographic barriers limiting treatment options for many people with multiple sclerosis (MS), a Case Western Reserve University researcher will use a new $4...
